• Mon. Oct 11th, 2021

MedX issues shares linked to debt settlement agreement

ByLois D. Voris

Mar 11, 2021


Content of the article

MISSISSAUGA, Ontario – MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce that effective December 22, 2020, it has completed the debt settlement announced in its press release dated December 22, 2020, pursuant to which she settled $ 65,000 in debt to an arm’s length professional advisor through the issuance of 500,000 common shares. The shares issued in connection with this debt settlement will be prohibited from trading for four months from the date of issue.

About MedX

MedX, headquartered in Mississauga, Ontario, is a leading skin health-focused medical device and software company with its SIAscopy telemedicine platform on DermSecure ™, using its SIAscopy ™ technology. SIAscopy is also integrated with its SIAMETRICS ™, SIMSYS ™ and MoleMate ™ products, which MedX manufactures in its ISO 13485 certified factory. SIAMETRICS ™, SIMSYS ™ and MoleMate ™ include portable devices that use patented technology using light and its transfer to visualize up to 2mm under moles and suspicious lesions in a painless and non-invasive way, with its software then creating real -time images allowing doctors and dermatologists to assess all types of moles. beauty or lesions in seconds. These products are approved by Health Canada, FDA, TGA, and CE for use in Canada, United States, Australia, New Zealand, European Union, Turkey, and Brazil. MedX also designs, manufactures and distributes quality therapeutic and dental photobiomodulation lasers to provide drug-free, non-invasive treatment for tissue damage and pain. www.medxhealth.com

Content of the article

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release may contain forward-looking statements, which reflect the Company’s current expectations regarding future events. Forward-looking statements involve risks and uncertainties.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20210104005826/en/

logo

Contacts

Rob von der Porten, Interim President and CEO
MedX Health Company
vondeporten@medxhealth.com

#distro



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *